Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of JUBILANT PHARMOVA . For more details, see the JUBILANT PHARMOVA quarterly results and JUBILANT PHARMOVA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.3 |
No. of shares | m | 159.28 |
1 Week | % | 8.3 |
1 Month | % | 24.7 |
1 Year | % | 130.3 |
52 week H/L | Rs | 676.9/299.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
JUBILANT PHARMOVA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 898 | 727 | 1,047 | 925 | 496 | |
Low | Rs | 617 | 230 | 251 | 385 | 269 | |
Sales per share (Unadj.) | Rs | 572.0 | 375.2 | 382.9 | 384.9 | 394.4 | |
Earnings per share (Unadj.) | Rs | 36.2 | 42.6 | 36.0 | 25.9 | -4.1 | |
Diluted earnings per share | Rs | 36.2 | 42.6 | 36.0 | 25.9 | -4.1 | |
Cash flow per share (Unadj.) | Rs | 59.5 | 63.9 | 57.9 | 49.9 | 30.7 | |
Dividends per share (Unadj.) | Rs | 4.50 | 5.00 | 5.00 | 5.00 | 5.00 | |
Adj. dividends per share | Rs | 4.50 | 5.00 | 5.00 | 5.00 | 5.00 | |
Avg Dividend yield | % | 0.6 | 1.0 | 0.8 | 0.8 | 1.3 | |
Book value per share (Unadj.) | Rs | 301.9 | 351.8 | 297.6 | 333.7 | 338.6 | |
Adj. book value per share | Rs | 301.9 | 351.8 | 297.6 | 333.7 | 338.6 | |
Shares outstanding (eoy) | m | 159.28 | 159.28 | 159.28 | 159.28 | 159.28 | |
Price / Sales ratio | x | 1.3 | 1.3 | 1.7 | 1.7 | 1.0 | |
Avg P/E ratio | x | 20.9 | 11.2 | 18.0 | 25.3 | -93.8 | |
P/CF ratio (eoy) | x | 12.7 | 7.5 | 11.2 | 13.1 | 12.4 | |
Price / Book Value ratio | x | 2.5 | 1.4 | 2.2 | 2.0 | 1.1 | |
Dividend payout | % | 12.4 | 11.8 | 13.9 | 19.3 | -122.7 | |
Avg Mkt Cap | Rs m | 120,691 | 76,220 | 103,365 | 104,317 | 60,873 | |
Total wages/salary | Rs m | 19,260 | 18,432 | 19,229 | 20,434 | 21,660 |
JUBILANT PHARMOVA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 91,108 | 59,758 | 60,985 | 61,302 | 62,817 | |
Other income | Rs m | 357 | 374 | 176 | 113 | 383 | |
Total revenues | Rs m | 91,466 | 60,132 | 61,162 | 61,415 | 63,201 | |
Gross profit | Rs m | 14,588 | 15,150 | 13,865 | 11,463 | 7,317 | |
Depreciation | Rs m | 3,709 | 3,398 | 3,489 | 3,817 | 5,540 | |
Interest | Rs m | 2,198 | 1,997 | 1,841 | 1,455 | 1,882 | |
Profit before tax | Rs m | 9,038 | 10,129 | 8,711 | 6,304 | 278 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 3,268 | 3,351 | 2,972 | 2,174 | 927 | |
Profit after tax | Rs m | 5,770 | 6,778 | 5,739 | 4,130 | -649 | |
Gross profit margin | % | 16.0 | 25.4 | 22.7 | 18.7 | 11.6 | |
Effective tax rate | % | 36.2 | 33.1 | 34.1 | 34.5 | 333.5 | |
Net profit margin | % | 6.3 | 11.3 | 9.4 | 6.7 | -1.0 |
JUBILANT PHARMOVA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 45,848 | 50,383 | 29,525 | 35,092 | 37,624 | |
Current liabilities | Rs m | 20,897 | 26,190 | 10,488 | 15,916 | 17,724 | |
Net working cap to sales | % | 27.4 | 40.5 | 31.2 | 31.3 | 31.7 | |
Current ratio | x | 2.2 | 1.9 | 2.8 | 2.2 | 2.1 | |
Inventory Days | Days | 7 | 10 | 18 | 21 | 25 | |
Debtors Days | Days | 51 | 79 | 49 | 55 | 56 | |
Net fixed assets | Rs m | 67,342 | 72,721 | 58,109 | 63,204 | 71,668 | |
Share capital | Rs m | 159 | 159 | 159 | 159 | 159 | |
"Free" reserves | Rs m | 47,929 | 55,880 | 47,248 | 52,990 | 53,772 | |
Net worth | Rs m | 48,089 | 56,039 | 47,407 | 53,149 | 53,931 | |
Long term debt | Rs m | 42,429 | 37,397 | 25,640 | 24,642 | 31,104 | |
Total assets | Rs m | 113,190 | 123,104 | 87,634 | 98,296 | 109,292 | |
Interest coverage | x | 5.1 | 6.1 | 5.7 | 5.3 | 1.1 | |
Debt to equity ratio | x | 0.9 | 0.7 | 0.5 | 0.5 | 0.6 | |
Sales to assets ratio | x | 0.8 | 0.5 | 0.7 | 0.6 | 0.6 | |
Return on assets | % | 7.0 | 7.1 | 8.6 | 5.7 | 1.1 | |
Return on equity | % | 12.0 | 12.1 | 12.1 | 7.8 | -1.2 | |
Return on capital | % | 12.4 | 13.0 | 14.4 | 10.0 | 2.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 18.9 | 22.6 | 14.9 | 0 | 4.1 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 17,227 | 13,515 | 9,117 | 3 | 2,564 | |
Fx inflow | Rs m | 12,422 | 15,515 | 11,207 | 1,580 | 7,100 | |
Fx outflow | Rs m | 17,227 | 13,515 | 9,117 | 3 | 2,564 | |
Net fx | Rs m | -4,805 | 2,000 | 2,090 | 1,577 | 4,536 |
JUBILANT PHARMOVA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 11,215 | 15,429 | 17,843 | 8,375 | 6,607 | |
From Investments | Rs m | -10,118 | -3,270 | -7,390 | -3,804 | -5,444 | |
From Financial Activity | Rs m | 6,574 | -10,504 | -17,094 | -326 | -1,567 | |
Net Cashflow | Rs m | 7,612 | 2,254 | -7,289 | 4,819 | 301 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Shyam S Bhartia | COMP SEC: Naresh Kapoor | YEAR OF INC: 1978 | BSE CODE: 530019 | FV (Rs): 1 | DIV YIELD (%): 0.7 |
Read: JUBILANT PHARMOVA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare JUBILANT PHARMOVA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.